$3M for Kala Pharmaceuticals

Xconomy Boston — 

Kala Pharmaceuticals, a stealthy Waltham, MA-based biotech startup, has raised $3 million in an equity and debt financing, according to an SEC filing. The firm’s board of directors includes the famous MIT inventor Bob Langer, Robert Paull, a managing partner of Lux Capital, Kevin Bitterman, a principal at Polaris Venture Partners, Justin Hanes, a professor of chemical and biomolecular engineering at Johns Hopkins University, and Robert Tepper, a partner at Third Rock Ventures, according to the filing. The startup previously raised $2 million in an equity financing in December 2009. The company does not appear to have a website, and it’s unclear what its specific focus is.